Chemotherapy can cause various changes in the liver that are detectable sonographically. Common findings include hepatomegaly (enlarged liver), increased echogenicity due to fatty infiltration, and possible development of liver lesions or nodules. Additionally, some chemotherapeutic agents may lead to hepatic steatosis or sinusoidal injury, which can also be visualized as altered liver texture or patterns on ultrasound. Regular sonographic monitoring is often necessary to assess these effects during treatment.
The liver's ability to repair itself after chemotherapy varies depending on several factors, including the type and dosage of chemotherapy, the individual's overall health, and existing liver function. Generally, it can take weeks to months for liver function to improve after chemotherapy. In some cases, liver recovery may be more prolonged if there are pre-existing liver conditions or additional stressors on the liver. Regular monitoring by a healthcare provider is essential to assess liver health during recovery.
Some patients with metastatic cancer of the liver can have their lives prolonged for a few months by chemotherapy, although cure is not possible.
B. kidneys and liver
B. kidneys and liver
If the chemo affects your liver, then yes
No! Chemotherapy puts an incredible strain on the liver. The last thing it needs is more poison to cope with.
Chemotherapy and radiation can potentially lead to liver damage, but they do not directly cause cirrhosis. Some chemotherapy drugs can induce liver toxicity, leading to inflammation or fibrosis over time, while radiation therapy targeting the liver may also result in radiation-induced liver disease. However, cirrhosis is typically a result of chronic liver conditions such as viral hepatitis or alcohol abuse rather than cancer treatments. Regular monitoring of liver function during and after treatment is important to identify any complications early.
Chemotherapy is treatment used to treat various cancers, the drugs destroy cancer cells or prevent them from growing. Chemotherapy can also be administered directly into the liver artery and is called intra-arterial chemotherapy. Liver tumors derive their blood supply from the hepatic artery, and intra-arterial administration will expose the tumor to very high doses of chemotherapy (100 - 400 times higher values than systemic infusion).This increased drug exposure achieves tumor shrinkage in 50 - 70% of patients. The two most commonly used drugs are 5 FU and FUDR. Administering combinations of drugs can improve the chance of tumor shrinkage.
The pump allows much higher concentrations of the cancer drug to be carried to the tumor than is possible with chemotherapy carried through the bloodstream.
Yes, Chronic hepatitis B may eventually cause liver cirrhosis and liver cancer, a fatal disease with very poor response to current chemotherapy. The infection is preventable by vaccination.
A person with jaundice can have chemotherapy. Jaundice is a disease of a blockage within the liver and/or bile ducts. If there is cancer causing the blockage/jaundice, then chemotherapy may help shrink the tumor to relieve the blockage and relieve the jaundice. The oncologist will decide which type of chemo and which dose is the most appropriate.
Yes, chemotherapy can lead to high ammonia levels in some patients. Certain chemotherapeutic agents can affect liver function or cause tissue breakdown, which may increase the production of ammonia. Additionally, some cancer treatments can lead to complications such as liver damage or metabolic disturbances, contributing to elevated ammonia levels in the blood. It's important for healthcare providers to monitor liver function and ammonia levels during chemotherapy.